Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 2260 of 6351
-
Organ shortage crisis: new study probes why families refuse donation
Knowledge-focused Recruiting nowIn 2024, 29,000 people are waiting for organ transplants in France, and only 6,034 transplants were performed during the year. 852 people died while waiting for a transplant. The gap between the number of available transplants and the number of patients waiting for transplants ha…
Sponsor: University Hospital, Strasbourg, France • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC
-
New diabetes drug aims to improve daily glucose control
Disease control OngoingThe purpose of this study is to see how well LY3938577 works and how safe it is compared to degludec in people with type 2 diabetes. Participation in the study will last about 26 weeks.
Phase 2 • Sponsor: Eli Lilly and Company • Aim: Disease control
Last updated Jul 15, 2026 00:00 UTC
-
Can Youth-Led HIV testing programs last? new study aims to find out
Prevention OngoingSustaining Innovative Tools to Expand Youth-Friendly HIV Self-Testing (S-ITEST), locally known as 4 Youth by Youth (4YBY) in Nigeria, builds on the investigator's previous efforts, which are detailed in ClinicalTrial ID#: NCT04070287, NCT03874663, and NCT04710784. Many adolescent…
Sponsor: Washington University School of Medicine • Aim: Prevention
Last updated Aug 12, 2026 00:00 UTC
-
Teaching parents to navigate health information may improve breastfeeding outcomes
Symptom relief CompletedThis study aims to evaluate the effects of a comprehensive breastfeeding education program based on a health literacy development strategy on maternal and paternal breastfeeding self-efficacy, fathers' breastfeeding support, parental health literacy, and breastfeeding outcomes. T…
Sponsor: Nigde Omer Halisdemir University • Aim: Symptom relief
Last updated Jul 26, 2026 00:00 UTC
-
New combo approach aims to stop pancreatitis after stone treatment
Prevention Recruiting nowThis study aims to determine whether combining aggressive intravenous hydration with indometacin is more effective at preventing pancreatitis after a Extracorporeal Shock Wave Lithotripsy (ESWL) than using indometacin alone. The study will involve patients who are scheduled to u…
Sponsor: Changhai Hospital • Aim: Prevention
Last updated Jun 27, 2026 12:06 UTC
-
Blockchain watchdogs take on hospital fraud in new trial
Knowledge-focused By invitation onlyThe PHX-AFK-US Protocol is a coalition-backed regulatory scaffold designed to restore healthcare integrity across U.S. facilities. It targets fraud, kickback schemes, and supply chain opacity through validator governance, smart contract enforcement, and public transparency. Ancho…
Sponsor: Truway Health, Inc. • Aim: Knowledge-focused
Last updated Jun 27, 2026 07:55 UTC
-
New antibody drug trial offers hope for Hard-to-Treat wet AMD
Disease control Recruiting nowStudy Design This is a Single-center, Phase I/II placebo-controlled study to assess the safety and efficacy of PRL3-zumab in patients with Neovascular Age-related Macular Degeneration (nAMD). PRL3-zumab will be administered intravenously in 2-week interval for 3 doses. Normal sa…
Phase 1/2 • Sponsor: Intra-IMMUSG Pte Ltd • Aim: Disease control
Last updated Jun 27, 2026 12:24 UTC
-
New pill aims to shrink fatty liver in 12 weeks
Disease control Recruiting nowPrimary Objective: • To evaluate the efficacy of HP515 tablets in participants with non-alcoholic fatty liver disease. Secondary objectives: * To evaluate the safety of HP515 tablets in participants with non-alcoholic fatty liver disease; * To evaluate the pharmacokinetic of H…
Phase 2 • Sponsor: Hinova Pharmaceuticals Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:07 UTC
-
Nature's wrinkle fighter? botanical extract put to the test
Symptom relief OngoingThis is a single-center, double-blinded, placebo-controlled, split-face, prospective clinical study to evaluate the anti-ageing efficacy and safety of a topical cosmetic formulation containing a botanical extract. 66 female subjects with dry skin were recruited. The study compare…
Sponsor: L'Oreal • Aim: Symptom relief
Last updated Aug 26, 2026 00:00 UTC
-
Heart study tests tailored drugs for mysterious chest pain
Knowledge-focused Recruiting nowCOMA.NET (Coronary Microcirculation Analysis Network) is a prospective, randomized, open-label, parallel-group clinical trial designed to determine whether endotype-guided pharmacotherapy is superior to standard care in improving quality of life in patients with ischemia with non…
Sponsor: Medical University of Bialystok • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:05 UTC
-
Lying on your back vs. your side: which is safer for kidney surgery?
Symptom relief Recruiting nowThis study aims to find out which surgical position is safer and works better for patients candidate to robot-assisted partial nephrectomy (RAPN) - a minimally invasive procedure to remove a small kidney tumor while preserving healthy kidney tissue. During this operation, the pa…
Sponsor: Niguarda Hospital • Aim: Symptom relief
Last updated Jun 27, 2026 07:58 UTC
-
New clinic aims to tackle muscle wasting in COPD patients
Disease control Recruiting nowSarcopenia, or skeletal muscle loss, impacts up to 40% of COPD patients and is a major cause for morbidity and mortality. Despite the high clinical significance of sarcopenia in COPD, the diagnosis remains elusive because accurate measures of skeletal muscle are not tested during…
Sponsor: The Cleveland Clinic • Aim: Disease control
Last updated Jun 27, 2026 07:56 UTC
-
New study tests simpler abortion pill regimen for early pregnancy
Disease control Not yet recruitingThe goal of this study is to evaluate the effectiveness, non-inferiority, and side-effect profile of an updated misoprostol-only regimen, as compared to the combined mifepristone-misoprostol regimen, among people seeking medication abortion (MAB) through 77 days of pregnancy in t…
Phase 4 • Sponsor: Ibis Reproductive Health • Aim: Disease control
Last updated Jun 27, 2026 07:54 UTC
-
New miRNA test could spot hidden virus after transplant
Diagnosis Not yet recruitingHuman cytomegalovirus (HCMV) infection is one of the most common and serious complications after allogeneic hematopoietic stem cell transplantation (allo-HSCT). Standard monitoring uses HCMV DNA testing, but this method may not detect the virus early enough to guide timely treatm…
Sponsor: Ting YANG • Aim: Diagnosis
Last updated Jun 27, 2026 07:53 UTC
-
New monitor aims to stop dangerous blood pressure drops during ICU dialysis
Disease control Recruiting nowThis single-center, crossover randomized controlled trial (HyPIR-ICU) investigates whether a Hypotension Prediction Index (HPI)-guided management strategy can reduce intradialytic hypotension (IDH) during prolonged intermittent renal replacement therapy (PIRRT) in critically ill …
Sponsor: Chulalongkorn University • Aim: Disease control
Last updated Jun 27, 2026 12:30 UTC
-
Shockwave and cold combo may ease stroke shoulder pain
Symptom relief CompletedThis study aims to find out whether combining two physical therapy treatments - Extracorporeal Shockwave Therapy and Cryoflow Therapy - can help reduce shoulder pain and improve function in patients who have developed rotator cuff tendonitis after a stroke. Participants will be d…
Sponsor: MTI University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
Pill vs. shot: which blood thinner better prevents deadly clots after emergency surgery?
Prevention Recruiting nowThe goal of this clinical trial is to learn if rivaroxaban works better than enoxaparin to prevent deep vein thrombosis (DVT) after emergency exploratory laparotomy in adults. It will also learn about the safety of rivaroxaban compared to enoxaparin. The main questions it aims t…
Phase 4 • Sponsor: Mayo Hospital Lahore • Aim: Prevention
Last updated Jun 27, 2026 07:58 UTC
-
New anxiety drug shows promise in early trial
Symptom relief Recruiting nowA placebo-controlled superiority design was used to evaluate the efficacy of 40 mg/ day of Crisugabalin capsules in the treatment of GAD.
Phase 2 • Sponsor: Anhui Medical University • Aim: Symptom relief
Last updated Jun 27, 2026 08:09 UTC
-
New blood markers could spot dangerous pregnancy complication earlier
Diagnosis Recruiting nowhis study investigates the effectiveness of three specific biological markers (biomarkers) in the blood-the sFlt-1/PlGF ratio, soluble endoglin (sEng), and osteoprotegerin (OPG)-to better diagnose and monitor preeclampsia. Preeclampsia is a serious pregnancy complication characte…
Sponsor: Ammar Jassim Abed • Aim: Diagnosis
Last updated Jun 27, 2026 08:12 UTC
-
New study tracks how well risankizumab tames ulcerative colitis in daily life
Disease control Recruiting nowUlcerative colitis (UC) is a type of inflammatory bowel disease that causes inflammation and bleeding from the lining of the rectum and colon (large intestine). This study will assess the change in disease activity of risankizumab treatment in adult participants with moderate to …
Sponsor: AbbVie • Aim: Disease control
Last updated Aug 16, 2026 00:00 UTC